Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Microsoft
MSFT
5
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
ADCT ADC Therapeutics
- 1.610
- -0.090-5.29%
Close Mar 21 16:00 ET
- 1.610
- 0.0000.00%
Post 16:22 ET
155.67MMarket Cap-0.67P/E (TTM)
1.670High1.570Low567.91KVolume1.660Open1.700Pre Close922.27KTurnover0.80%Turnover RatioLossP/E (Static)96.69MShares5.38052wk High-0.91P/B113.77MFloat Cap1.39052wk Low--Dividend TTM70.66MShs Float56.590Historical High--Div YieldTTM5.88%Amplitude0.360Historical Low1.623Avg Price1Lot Size
About ADC Therapeutics Company
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Company Profile
SymbolADCT
Company NameADC Therapeutics
Listing DateMay 15, 2020
Issue Price19.00
Founded2011
CEOMr. Ameet Mallik
MarketNYSE
Employees274
Fiscal Year Ends12-31
AddressBiop?le,Route de la Corniche 3B
CityEpalinges
ProvinceVaud
CountrySwitzerland
Zip Code1066
Phone41-212-653-02-00
Company Executives
- Name
- Position
- Salary
- Ameet Mallik
- Chief Executive Officer and Director
- 3.78M
- Mohamed Zaki, M.D.,PhD
- Chief Medical Officer
- 4.40M
- Jose Carmona
- Chief Financial Officer
- 1.26M
- Lisa Michelle Kallebo
- Corporate Controller and Chief Accounting Officer
- --
- Peter J. Graham
- Chief Legal Officer
- --
- Ron Squarer
- Chairman of the Board
- 526.73K
- Thomas Pfisterer
- Director
- 194.30K
- Dr. Victor Sandor, C.M.,M.D.
- Independent Director
- 227.72K
- Peter Hug, PhD
- Lead Independent Director
- 212.61K
- Dr. Tyrell J. Rivers, PhD
- Independent Director
- --
- Robert W. Azelby
- Independent Director
- 127.67K
- Viviane Monges
- Independent Director
- 231.33K
- Dr. Jean-Pierre Bizzari, M.D.
- Independent Director
- 197.81K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call